Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 46,630 shares at $57.74 ($2.7M) on 2020-11-02, disclosed to the SEC on 2020-11-04.
Open-market sale of $2.7M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.03 | 7,205 | $411K | 15.3% |
| 2 | $57.03 | 7,205 | $411K | 15.3% |
| 3 | $57.74 | 12,611 | $728K | 27.1% |
| 4 | $57.74 | 12,611 | $728K | 27.1% |
| 5 | $58.53 | 3,499 | $205K | 7.6% |
| 6 | $58.53 | 3,499 |
| $205K |
| 7.6% |
| Total | $57.64 avg | 46,630 | $2.7M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |